Zepzelca
Term · Oncology and biomedicine · MLC-T-ONC-009472
A drug used to treat adults with small cell lung cancer that has spread to other parts of the body and got worse during or after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Zepzelca may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called lurbinectedin.
| Identifier | MLC-T-ONC-009472 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | lurbinectedin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009472",
"term": "Zepzelca",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with small cell lung cancer that has spread to other parts of the body and got worse during or after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Zepzelca may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called lurbinectedin.",
"synonyms": [
"lurbinectedin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/zepzelca/"
}
Record 17,623 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.